Cladribine
"Cladribine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An antineoplastic agent used in the treatment of lymphoproliferative diseases including hairy-cell leukemia.
| Descriptor ID |
D017338
|
| MeSH Number(s) |
D03.633.100.759.590.138.300.200 D03.633.100.759.590.138.325.075 D13.570.230.229.075 D13.570.583.138.300.200 D13.570.583.138.325.075 D13.570.800.096.300.200
|
| Concept/Terms |
Cladribine- Cladribine
- 2-Chlorodeoxyadenosine
- 2-Chloro-2'-deoxyadenosine
- 2'-Deoxy-2-chloroadenosine
|
Below are MeSH descriptors whose meaning is more general than "Cladribine".
Below are MeSH descriptors whose meaning is more specific than "Cladribine".
This graph shows the total number of publications written about "Cladribine" by people in this website by year, and whether "Cladribine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2021 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cladribine" by people in Profiles.
-
Miravalle AA, Katz J, Robertson D, Hayward B, Harlow DE, Lebson LA, Sloane JA, Bass AD, Fox EJ. CLICK-MS and MASTER-2 Phase IV?trial design: cladribine tablets in suboptimally controlled relapsing multiple sclerosis. Neurodegener Dis Manag. 2021 04; 11(2):99-111.
-
Nagourney RA, Evans SS, Messenger JC, Su YZ, Weisenthal LM. 2 chlorodeoxyadenosine activity and cross resistance patterns in primary cultures of human hematologic neoplasms. Br J Cancer. 1993 Jan; 67(1):10-4.